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for the use of skip incisions to gain exposure of the GSV
for side branch occlusion.9,10 Long flexible valvulotomes
allow for valve lysis through the distal end of the vein
avoiding the need for additional incisions for this portion
of the procedure. Side branch occlusion with coils have
been shown to limit the number of skin incisions and
reduce wound complications, hospital stay, and cost.11,12
Endoscopic equipment to harvest the GSV for use in
bypass surgery has recently been developed and used with
encouraging results in reducing wound infection and scar-
ring in coronary artery and lower extremity bypass
grafts.13,14 Success with endoscopic vein harvest (EVH) in
reducing complications in patients undergoing infrain-
guinal bypass grafting13 led us to evaluate the use of the
Endopath system (Ethicon, Somserset, NJ) in performing
femoral to infrapopliteal artery in situ bypass grafts for
limb-threatening ischemia.
MATERIALS AND METHOD
Over a 24-month period we evaluated 25 consecutive
in situ bypass grafts performed with EVH equipment. The
results achieved with this method were compared with a
retrospective review of our previous 25 in situ bypass
grafts done with standard long-skin incisions over a 30-
month period. The age and medical comorbidities such as
diabetes mellitus, a history of coronary artery disease,
chronic obstructive pulmonary disease, and a history of
end-stage renal disease were recorded for each patient.
The performance of distal arterial bypass grafts with in
situ greater saphenous vein (GSV) is a well-established
technique for the treatment of lower limb-threatening
ischemia. The durability and excellent results of the in situ
technique have been demonstrated by many authors.1-3
Some surgeons prefer to use a reversed vein technique,
and no significant differences have been shown between
these methods in terms of patency and limb salvage.1,4,5
However, wound complications with in situ bypass grafts
performed with standard long-leg incisions have ranged
from 5% to 20%, which increases hospital stay and cost.6-8
Proponents of the in situ method have been develop-
ing methods to limit the size of the incisions to reduce
wound complications. The use of the angioscope or intra-
operative venography to locate side branches has allowed
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Objective: Lower extremity arterial reconstructions with in situ greater saphenous vein (GSV) are an important com-
ponent of limb salvage surgery. Initially, the procedure was performed through continuous skin incisions for side
branch occlusion and valve lysis with a wound complication rate of 5% to 25%. To decrease these complications, we
used endoscopic GSV harvest equipment in 25 in situ vein bypass grafts in 25 patients performed over 24 months.
Methods: The procedures were performed with three skin incisions: two for arterial access and a 2-cm incision above the
knee to insert the Endopath device (Ethicon) to locate and clip the GSV side branches. After completion of the prox-
imal anastomosis, the valves were lysed through the distal end of the vein with a flexible valvulotome. Completion
cineangiography was performed to confirm side branch occlusion and evaluate the entire reconstruction. The results of
this technique were compared with our last 25 in situ bypass grafts done with standard long incisions.
Results: In the endoscopic group there was one (4%) minor wound complication (cellulitis). No postoperative arterio-
venous fistulas were detected by means of duplex examination, and the average hospital stay was 6.2 ± 1 days. One graft
closed at 9 months as a result of distal vein hyperplasia, but the other grafts have remained patent, with follow-up from
6 to 30 months (mean, 18 months). Patients with the standard in situ bypass grafts had significantly (P < .05) more
wound complications (20%) and longer average hospital stay (9.2 ± 2 days) than the endoscopic group. Patency rates
were comparable for both groups.
Conclusion: These results show that less invasive endoscopic in situ bypass grafting minimizes wound complications and
reduces the need for hospitalization without decreasing patency or increasing operative time. (J Vasc Surg
2001;34:668-72.)
All patients with extensive infrainguinal occlusive dis-
ease requiring femoral to infrapopliteal artery reconstruc-
tion and an intact GSV documented with preoperative
vein mapping were entered into the study. All patients
underwent bypass graft evaluation with color flow duplex
before discharge. Follow-up examination for both groups
included a physical examination and duplex evaluation of
the in situ graft at 1 month, 3 months, 6 months, and then
at 6-month intervals thereafter. The hospital length of
stay, incidence of wound infections, and postoperative
arteriovenous fistulas were recorded for each patient. The
primary patency rate was calculated from the date of the
last known patency by physical examination or by nonin-
vasive studies according to the standards of the Society for
Vascular Surgery and the International Society for
Cardiovascular Surgery.15 The primary patency rates were
calculated by means of the life-table method. The calcula-
tion of primary patency did not include any graft revisions.
Differences between groups were calculated with a 2-
tailed Student t test analysis.
Before the skin incision, all patients received 1 g of a
cephalosporin for prophylaxis. The endoscopic in situ
bypass grafts were performed with three skin incisions:
two for arterial access and a 2-cm incision above the knee
to insert the Endopath device (Ethicon). Bypass grafts to
the anterior tibial or dorsalis pedis artery required an addi-
tional calf incision for GSV exposure and mobilization.
The scope was inserted into the above-knee incision, and
all of the branches of the GSV were interrupted up to the
femoral incision with a 5-mm clip applier (Figs 1 and 2).
The calf incision was used to expose the GSV and to gain
access to the peroneal or posterior tibial artery. In addi-
tion, this incision was used to insert the scope and ligate
GSV side branches at the knee. After the side branches
were clipped, the GSV was divided at the saphenofemoral
junction and spatulated for the proximal anastomosis. The
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distal vein was then divided, and a flexible valvulotome
(WL Gore, Flagstaff, Ariz) passed with the dull head up to
the proximal opening of the vein. The 2-mm head was
applied and pulled back into the vein. After completion of
the proximal anastomosis, the valvulotome was passed
twice through the vein to lyse the valves. A third pass of
the valvulotome was performed with a 3-mm cutting
head; the larger cutting head passed without difficulty
once flow had been established in the vein. The distal
anastomosis was performed under tourniquet control. A
completion cineangiography was performed of the entire
bypass graft from the groin down to confirm side branch
occlusion and evaluate the distal anastomosis (Fig 3). If
any arteriovenous fistulas with flow into the deep system
or adjacent superficial veins were detected, these were
clipped with the endoscope.
RESULTS
A total of 25 endoscopic in situ bypass grafts were per-
formed on 13 men and 12 women (average age, 67 ± 14
years). The results in this group were compared with 25
standard in situ bypass grafts performed in 14 men and 11
women (average age, 69 ± 13 years). Both groups were
similar in their incidence of diabetes mellitus, congestive
heart failure, and other comorbidities (Table I). Operative
indications were either rest pain or gangrene in both
groups with most of the bypass grafts being performed to
the peroneal or posterior tibial artery (Table II). In the
endoscopic group, 10 of the 14 patients with gangrene
underwent a minor amputation. Of the 10, 5 had single-
toe amputations, 4 had multiple-toe amputations, and 
1 had a transmetatarsal amputation. In the standard
group, 11 of the 15 patients with gangrene had minor
amputations. Of the 11, 6 had single-toe amputations, 4
had multiple-toe amputations, and 1 had a transmetatarsal
amputation.
Fig 1. Endoscope inserted in above-knee incision with 5-mm
clip applier being inserted. Note below-knee incision used to
expose distal GSV (encircled with vessel loop) and posterior tib-
ial artery.
Fig 2. View through endoscopic vein dissector. Illustration
shows 5-mm clip applier being placed on GSV side branch.
One postoperative hematoma was noted, which led to
a minor wound infection (4%) in the endoscopic group
that was managed with oral antibiotics. Five wound com-
plications (20%) were found in the standard group. Three
of these patients had thigh wound infections that required
readmission to the hospital for intravenous antibiotics,
debridment, and wound care. There was one postopera-
tive myocardial infarction in the endoscopic group (4%)
and two myocardial infarctions (8%) in the standard in situ
group. There were no perioperative deaths in either
group. One arteriovenous fistula was noted in a patient in
the endoscopic group 6 months postoperatively when a
palpable thrill was noted during a physical examination,
and this required ligation. Two arteriovenous fistulas were
noted postoperatively in the standard in situ group: one
was found during a physical examination and the other
during a duplex examination. Both of these fistulas
required ligation because of the flow into the deep system
verified with duplex scan.
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The 1-year cumulative primary patency rate was 91% ±
4% for the endoscopic group and 92% ± 5% for the stan-
dard group. Two below-knee amputations were per-
formed during the first year in the standard in situ group:
one after graft closure and one because of an ongoing foot
infection. One below-knee amputation was performed in
the endoscopic group in a patient with a patent bypass
graft but who had a recurrent infection in a partial foot
amputation 3 weeks after the original procedure. One-year
cumulative limb salvage rates were 92% ± 3% and 94% ±
5% for the standard and endoscopic groups, respectively.
The average hospital stay was 6.2 ± 1 days for the endo-
scopic group, which was significantly shorter than the 9.2
± 1 days for the standard in situ group (P < .05). Operative
times in the two groups were comparable (Table II).
DISCUSSION
The use of endoscopic equipment is a useful way to
minimize the wound complications of traditional in situ
bypass grafts performed with long incisions. Alternative
approaches to limit incision size have included venography
and angioscopy to locate the side branches of the GSV and
allow branch occlusion through small skip incisions.10
Though these methods decrease wound complications,
they are time-consuming. Rosenthal et al have used coils
to occlude the GSV side branches and obviate the need for
thigh incisions in these patients. The use of a coil occlu-
sion system has been shown to decrease wound complica-
tions and decrease the hospital length of stay and cost.16,17
An analysis of cost in a European study also showed that
the increased cost of these procedures was offset by the
decreased hospital stay, so that the overall costs were
decreased.18
EVH has been shown to decrease the wound compli-
cations associated with GSV harvest for lower extremity
bypass or coronary bypass grafting. Our experience and
that of others with endoscopic equipment for infrainguinal
bypass grafting with reversed GSV demonstrated a
decrease in wound complications.13,14 These results sup-
ported the application of this technology to use an endo-
scopic approach to in situ bypass grafts.
Initial concern about tunnel bleeding and the devel-
opment of significant hematoma formation were
unfounded because only one patient had a detectable
wound hematoma and cellulitis that responded well to an
oral antibiotic. The remaining patients experienced no
serious wound problems. Circumferential dissection of the
GSV proved unnecessary to identify the side branches; this
minimal disruption of the vein may minimize significant
tunnel bleeding. In addition, any large anterior branches
were clipped and divided to prevent disruption by the
manipulation of the scope in the tunnel. We also worried
that GSV exposure to the endoscopic equipment could
lead to missed side branches and arteriovenous fistulas.
However, one significant postoperative arteriovenous fis-
tula was detected in the endoscopic group, and this was
easily ligated as an outpatient procedure. Postoperative
routine duplex scan has revealed that small vein branches
Fig 3. A, This completion angiogram shows GSV in thigh of a
patient undergoing femoral-to-peroneal artery bypass graft.
Arrow points to small residual arteriovenous fistula that was
occluded with a clip. B, This completion angiogram shows distal
portion of GSV in same patient with no arteriovenous fistula
demonstrated and flow through distal arteries and excellent flow
through distal anastomosis and posterior tibial artery.
A
B
(< 2 mm) without flow into the deep system seen on com-
pletion cineangiography closed spontaneously after opera-
tion. Other authors have also documented that small
arteriovenous fistulas do not have a significant impact on
graft patency or limb salvage.19,20 However, it must be
noted that arteriovenous fistulas that cause a flow reduc-
tion in the distal bypass graft can lead to bypass occlusion
and must be ligated.
We did not observe any early closure (< 30 days) of
the bypass grafts in the endoscopic group such as has been
noted by the groups using coil occlusion.16,17 This may be
due to our utilizing an external mechanism of side branch
occlusion that minimizes the need for instrumentation
within the vein lumen. In the report in which coil occlu-
sion was used, early closures, primarily in veins from 2.5 to
3 mm in diameter, were noted.
The endoscopic technique significantly decreased our
wound complications when compared with our previous
results with a standard in situ technique. Patients experi-
enced a decrease in postoperative pain and were able to
ambulate earlier, leading to earlier discharge. There was an
average reduction of 3 days in our patient length of stay.
The cost of the disposable endoscope was approximately
$300 per case, and this can be used with a standard laparo-
scopic imaging system. The flexible valvulotome cost
about $250 per case. Clearly, the reduced length of stay
for these patients would offset the small increase in cost
for the endoscopic system. In addition, the endoscopic
technique did not increase our operative time when com-
pared with the standard technique. Other groups have
reported success with an endoscopic approach to in situ
bypass grafts, although these reports contained fewer
patients with a shorter follow-up than our series.21,22
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CONCLUSION
An endoscopic approach to in situ bypass grafts
proved to be safe and effective for performing lower
extremity arterial reconstructions. This technique pro-
vided a decrease in length of stay with equivalent patency
when compared with a standard in situ approach with long
incisions. Further evaluation will be required to ensure
that this technique provides continued favorable long-
term results.
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